Marc Schrader joined Santhera Pharmaceuticals as Head of Technical Development & Operations in September 2022 and has over 20 years of experience in the pharmaceutical industry. Previously, he held diverse pharmaceutical development, CMC and drug product operations leadership roles for small molecules across three organizations, Tillotts Pharma AG, Actelion Pharmaceuticals Ltd and Janssen Pharmaceutica N.V./Johnson & Johnson. On this basis, Marc has extensive in CMC dealing with complex global pharmaceutical development programs of new chemical entities (small molecules) in early and late clinical stage, clinical and commercial production, product life cycle management, outsourcing and CDMO management, CMC due diligence, CMC regulatory affairs and cGMP.

Marc is a Pharmacist by training and holds a scientific degree in pharmaceutical medicine from the European Center of Pharmaceutical Medicine (ECPM).